268 related articles for article (PubMed ID: 9698007)
1. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.
Lin PP; Jaffe N; Herzog CE; Costelloe CM; Deavers MT; Kelly JS; Patel SR; Madewell JE; Lewis VO; Cannon CP; Benjamin RS; Yasko AW
Cancer; 2007 Feb; 109(3):603-11. PubMed ID: 17177205
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
4. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
[TBL] [Abstract][Full Text] [Related]
6. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
Sami SH; Rafati AH; Hodjat P
Saudi Med J; 2008 Aug; 29(8):1124-9. PubMed ID: 18690304
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
8. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.
Shamberger RC; Laquaglia MP; Krailo MD; Miser JS; Pritchard DJ; Gebhardt MC; Healey JH; Tarbell NJ; Fryer CJ; Meyers PA; Grier HE
J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1154-61. PubMed ID: 10838532
[TBL] [Abstract][Full Text] [Related]
9. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
10. [Pediatric Ewing sarcoma of the rib: role of neoadjuvant chemotherapy in tumoral shrinking and sterilization. A case report].
Zidane A; Traibi A; Arsalane A; Atoini F; Ouriachi F; Hammoumi M; Kabiri EH
Rev Pneumol Clin; 2011 Dec; 67(6):371-4. PubMed ID: 22137283
[TBL] [Abstract][Full Text] [Related]
11. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM
Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.
Sindhu II; Mehreen A; Wali RM; Abubakar M
J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568
[TBL] [Abstract][Full Text] [Related]
13. Oncological outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities.
Gibbs CP; Peabody TD; Mundt AJ; Montag AG; Simon MA
J Bone Joint Surg Am; 1997 Jun; 79(6):888-97. PubMed ID: 9199387
[TBL] [Abstract][Full Text] [Related]
14. The role of surgery and resection margins in the treatment of Ewing's sarcoma.
Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
Clin Orthop Relat Res; 2001 Nov; (392):394-9. PubMed ID: 11716413
[TBL] [Abstract][Full Text] [Related]
15. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.
Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC
Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931
[TBL] [Abstract][Full Text] [Related]
16. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools.
Righi A; Pacheco M; Palmerini E; Carretta E; Gambarotti M; Longhi A; Magagnoli G; Sbaraglia M; Manfrini M; Picci P; Dei Tos AP
Eur J Surg Oncol; 2021 Jul; 47(7):1778-1783. PubMed ID: 33622576
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
[TBL] [Abstract][Full Text] [Related]
19. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.
Shamberger RC; LaQuaglia MP; Gebhardt MC; Neff JR; Tarbell NJ; Marcus KC; Sailer SL; Womer RB; Miser JS; Dickman PS; Perlman EJ; Devidas M; Linda SB; Krailo MD; Grier HE; Granowetter L
Ann Surg; 2003 Oct; 238(4):563-7; discussion 567-8. PubMed ID: 14530727
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.
Picci P; Rougraff BT; Bacci G; Neff JR; Sangiorgi L; Cazzola A; Baldini N; Ferrari S; Mercuri M; Ruggieri P
J Clin Oncol; 1993 Sep; 11(9):1763-9. PubMed ID: 8355043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]